Shandong Shanda Wit Science and Technology Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 25.22%

Shandong Shanda Wit Science and Technology Co Ltd (000915) has an Asset Resilience Ratio of 25.22% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital position of Shandong Shanda Wit Science and Technolo to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥1.21 Billion
≈ $176.44 Million USD Cash + Short-term Investments

Total Assets

CN¥4.78 Billion
≈ $699.46 Million USD All company assets

Resilience Assessment

Very High
Financial Resilience Level

Asset Resilience Ratio Trend (1999–2024)

This chart shows how Shandong Shanda Wit Science and Technology Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Shandong Shanda Wit Science and Technolo total assets.

Liquid Assets Composition Over Time

This chart breaks down Shandong Shanda Wit Science and Technology Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Shandong Shanda Wit Science and Technolo long-term investment intensity to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥1.21 Billion 25.22%
Total Liquid Assets CN¥1.21 Billion 25.22%

Asset Resilience Insights

  • Very High Liquidity: Shandong Shanda Wit Science and Technology Co Ltd maintains exceptional liquid asset reserves at 25.22% of total assets.
  • This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
  • The company has significant short-term investments, indicating active treasury management.

Shandong Shanda Wit Science and Technology Co Ltd Industry Peers by Asset Resilience Ratio

Compare Shandong Shanda Wit Science and Technology Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
Drug Manufacturers - Specialty & Generic 1.54%
Yunnan Baiyao Group Co Ltd
SHE:000538
Drug Manufacturers - Specialty & Generic 8.38%
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317
Drug Manufacturers - Specialty & Generic 6.62%
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
Drug Manufacturers - Specialty & Generic 4.94%
Harbin Gloria Pharmaceuticals
SHE:002437
Drug Manufacturers - Specialty & Generic 9.04%
Jiuzhitang Co Ltd
SHE:000989
Drug Manufacturers - Specialty & Generic 7.86%
Renhe Pharmacy Co Ltd
SHE:000650
Drug Manufacturers - Specialty & Generic 37.54%
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557
Drug Manufacturers - Specialty & Generic 0.29%

Annual Asset Resilience Ratio for Shandong Shanda Wit Science and Technology Co Ltd (1999–2024)

The table below shows the annual Asset Resilience Ratio data for Shandong Shanda Wit Science and Technology Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 19.47% CN¥960.04 Million
≈ $140.48 Million
CN¥4.93 Billion
≈ $721.55 Million
-3.88pp
2023-12-31 23.35% CN¥1.21 Billion
≈ $177.65 Million
CN¥5.20 Billion
≈ $760.67 Million
+3.13pp
2022-12-31 20.23% CN¥948.85 Million
≈ $138.85 Million
CN¥4.69 Billion
≈ $686.37 Million
+1.89pp
2021-12-31 18.34% CN¥721.61 Million
≈ $105.59 Million
CN¥3.94 Billion
≈ $575.88 Million
+17.51pp
2019-12-31 0.82% CN¥26.00 Million
≈ $3.80 Million
CN¥3.15 Billion
≈ $461.30 Million
+0.77pp
2016-12-31 0.06% CN¥1.43 Million
≈ $209.78K
CN¥2.48 Billion
≈ $363.23 Million
+0.04pp
2005-12-31 0.02% CN¥148.10K
≈ $21.67K
CN¥952.21 Million
≈ $139.34 Million
0.00pp
2004-12-31 0.02% CN¥150.00K
≈ $21.95K
CN¥755.44 Million
≈ $110.54 Million
0.00pp
2003-12-31 0.02% CN¥150.00K
≈ $21.95K
CN¥715.07 Million
≈ $104.64 Million
-5.22pp
2001-12-31 5.24% CN¥25.36 Million
≈ $3.71 Million
CN¥484.25 Million
≈ $70.86 Million
-1.69pp
2000-12-31 6.93% CN¥27.68 Million
≈ $4.05 Million
CN¥399.55 Million
≈ $58.47 Million
-1.14pp
1999-12-31 8.07% CN¥29.89 Million
≈ $4.37 Million
CN¥370.30 Million
≈ $54.19 Million
--
pp = percentage points

About Shandong Shanda Wit Science and Technology Co Ltd

SHE:000915 China Drug Manufacturers - Specialty & Generic
Market Cap
$823.99 Million
CN¥5.63 Billion CNY
Market Cap Rank
#9862 Global
#2570 in China
Share Price
CN¥24.03
Change (1 day)
+0.04%
52-Week Range
CN¥23.70 - CN¥35.60
All Time High
CN¥45.34
About

Shandong Wit Dyne Health Co.,Ltd. engages in the pharmaceutical business in China. Its medical products include azithromycin granules, licorice zinc granules, compound calcium carbonate, vitamin AD drops, epalrestat tablets, valsartan hydrochlorothiazide gel, roxithromycin, rosiglitazone tartrate tablets, and glimepiride tablets. The company also provides dextran iron granules, oral rehydration s… Read more